🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Cystic Fibrosis (CF)

Sinonasal Therapies and Histologic Correlations of Patients With Cystic Fibrosis in the Era of Highly Effective Modulator Therapy NCT06996951Phase 31 site📍 Indianapolis Indiana University · Tests: STOP NASAL SALINE IRRIGATION WITH OR WITHOUT STEROID, CONTINUE NASAL SALINE IRRIGATION WITH OR WITHOUT STEROID Regional Monitoring of CF Lung Disease NCT06339593EARLY Phase 11 site📍 Cincinnati Children's Hospital Medical Center, Cincinnati · Tests: Airway-clearance vest, Hyperpolarized Xe129 Cystic Fibrosis in the Kidney: Monitoring the Effectiveness of Elexacaftor/tezacaftor/ivacaftor in Urine After a Short Pause of Therapy NCT05818319NA1 site📍 Aarhus C University of Aarhus · Tests: 12 hours ETI pause, 36 hours ETI pause, 60 hours ETI pause Exercises' Effect on Muscle Strength, Aerobic Capacity and Respiratory Functions in Cystic Fibrosis NCT07508904NA1 site📍 Lahore Riphah International University · Tests: Arm Cycle Ergometry, Leg Cycle Ergometry Autogenic Drainage Versus Mechanical Percussion in Children With Cystic Fibrosis NCT07729787NA1 site📍 Multan Khurd Riphah International University · Tests: Autogenic Drainage, Mechanical Percussion Prevalence of Exercise-induced Ventilatory Limitation and Associated Factors in Patients With Cystic Fibrosis Receiving Elexacaftor-Tezacaftor-Ivacaftor NCT07314229NA1 site📍 Lille University Hospital, Lille · Tests: Measurement of resistance through forced oscillations and continuous measurement of ventilation and inspiratory capacit… Standardizing Treatments for Pulmonary Exacerbations - Aminoglycoside Study NCT05548283Phase 460 sites📍 Birmingham📍 Tucson📍 La Jolla Chris Goss · Tests: Beta-lactam antibiotic, Aminoglycoside Regional Phenotyping of CF and Non-CF Bronchiectasis NCT04793867n/a1 site📍 Cincinnati Children's Hospital Medical Center, Cincinnati · Tests: Xenon A Precision Medicine Approach to Assess Protein Function Loss and the Potential for CFTR Function Restoration in Cystic Fibrosis and Related Disorders NCT07889973n/a3 sites📍 Catania📍 Genova📍 Milan Istituto Giannina Gaslini Development and Validation of a Disease Specific PROM to Assess Abdominal Involvement in Patients With CF (CFAbd-Score) NCT03052283n/a2 sites📍 Brandenburg an der Havel📍 Brandenburg an der Havel Medizinische Hochschule Brandenburg Theodor Fontane · Tests: Questionnaire Patient Reported Outcome Measure (PROM) Population Pharmacokinetics of Elexacaftor-tezacaftor-ivacaftor in a Paediatric Population NCT07303621n/a1 site📍 Bron Hospices Civils de Lyon · Tests: There is no intervention as this is a prospective pharmacokinetics study. Canadian Observational Study Evaluating the Long-term IMPACT of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Modulators on People With CF NCT05200429n/a2 sites📍 Vancouver📍 Vancouver University of British Columbia · Tests: Trikafta NCCR AntiResist:: New Approaches to Combat Antibiotic-resistant Bacteria NCT05017766n/a1 site📍 Basel University Hospital, Basel, Switzerland · Tests: analysis of antimicrobial resistance Personalized Mobile Health Platform to Promote Physical Activity in Adolescents and Young Adults With Cystic Fibrosis NCT06616857NA1 site📍 Jacksonville Nemours Children's Clinic · Tests: NUDGE, Education Epididymis Protein 4 and Pulmonary Function With Quality Improvement Protocol Among Cystic Fibrosis Patients NCT06915961n/a1 site📍 Cairo Ain Shams University Lung Transplant READY CF 2: CARING CF Ancillary RCT NCT06032273NA1 site📍 Seattle University of Washington · Tests: Investigator-designed lung transplant education website Skin-interfaced Colorimetric Bifluidic Sweat Sensor Device for the Diagnosis of Cystic Fibrosis (CF) NCT05998629NA1 site📍 Hershey Milton S. Hershey Medical Center · Tests: a skin-interfaced colorimetric bifluidic sweat device with two synchronous channels, Standard of Care laboratory proced… Identifying the Causes and Risk Factors of Pulmonary Exacerbations in Cystic Fibrosis NCT06940531n/a18 sites📍 Manchester📍 Birmingham📍 Blackpool Alexander Horsley Modulate-CF: Cystic Fibrosis Transmembrane Regulator (CFTR) Biomarker Study to Evaluate the Rescue of Mutant CFTR in Patients With Cystic Fibrosis Treated With CFTR-modulators NCT04732910n/a4 sites📍 Berlin📍 Giessen📍 Hanover Charite University, Berlin, Germany · Tests: Treatment with cystic fibrosis transmembrane regulator (CFTR) modualtors Ivacaftor, Lumacaftor-Ivacaftor, Tezacaftor-Iv… Diagnostic Value of Oropharyngeal Suction and Effect of Respiratory Physiotherapy on the Detection of Microorganisms in the Pediatric Patient NCT07903792NA1 site📍 Sabadell Corporacion Parc Tauli · Tests: Respiratory physiothperapy, Oropharyngeal suction, Oropharyngeal swab, Induced Sputum Proof of Principle Study for an Efficacy Trial of Linaclotide for Cystic Fibrosis NCT07569419EARLY Phase 11 site📍 Nottingham University of Nottingham · Tests: Linaclotide 290 micrograms, Lactose placebo pill Lung Disease and Its Affect on the Work of White Blood Cells in the Lungs NCT01851642n/a1 site📍 Gainesville University of Florida · Tests: History and physical exam., Blood draw., Pulmonary function testing., Albuterol inhaler. IV Gallium Study for Patients With Cystic Fibrosis Who Have NTM (ABATE Study) NCT04294043Phase 110 sites📍 Birmingham📍 Denver📍 Baltimore Chris Goss · Tests: Gallium nitrate PERCE-MUCO: Perceptions and Expectations of People With Cystic Fibrosis Regarding a Change in Treatment NCT07885410n/a12 sites📍 Caen📍 Giens📍 Grenoble Fondation Ildys Evaluation of Ventilation Defects Downstream of Mucus Plugs in Patients With Muco-Obstructive Lung Disease NCT06985225n/a1 site📍 Kansas City University of Kansas Medical Center · Tests: Hyperpolarized 129 Xenon A Phase 1/2 Trial of SP-101 for the Treatment of Cystic Fibrosis (CF) NCT06526923Phase 1, Phase 24 sites📍 Kansas City📍 Boston📍 New York Spirovant Sciences, Inc. · Tests: SP-101 and doxorubicin Cohort 1, SP-101 and doxorubicin Cohort 2 Study to Enable New Diagnostics for Pulmonary Microbes in People With CF NCT07312734n/a9 sites📍 La Jolla📍 Minneapolis📍 St Louis Chris Goss Novel Sensors and Artificial Intelligence for Detection of Acute Pulmonary Exacerbations in Cystic Fibrosis and Bronchiectasis NCT07289100n/a1 site📍 Cambridge Papworth Hospital NHS Foundation Trust · Tests: Non-Interventional Study Understanding Inflammation, InFection and Interventions in Severe Exacerbations of Cystic Fibrosis NCT07484607n/a6 sites📍 Cardiff📍 Exeter📍 Leeds Alexander Horsley Gastrointestinal Response of Pediatric Cystic Fibrosis Patients on Mediterranean Diet NCT07223255NA2 sites📍 Lebanon📍 Manchester Dartmouth-Hitchcock Medical Center · Tests: Mediterranean diet
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy